Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
HALOZYME THERAPEUTICS, INC. has filed 1,516 SEC EDGAR filings since 21 Sep 2001

SEC filing history

Showing 1-10 of 10 matching filings.

Per page
25
Current page
1
SC 13D/A File 005-78830

SC 13D/A

Filing date
05 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-78830

SC 13D/A

Filing date
03 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-78830

SC 13D/A

Filing date
07 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-78830

SC 13D/A

Filing date
28 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-78830

SC 13D/A

Filing date
16 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-78830

SC 13D/A

Filing date
26 Jul 2017
Reporting date
Not listed
Next action
Verify source filing
SC 13D/A File 005-78830

RANDAL J. KIRK SC 13D A NO. 7 5-31-2016 (HALOZYME THERAPEUTICS)

Filing date
02 Jun 2016
Reporting date
Not listed
Next action
Verify source filing
SC 13D/A File 005-78830

RANDAL J. KIRK SC13D A#6 6-1-2012

Filing date
06 Jun 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-78830

KIRK RANDAL J SC 13D/A 2-13-2012

Filing date
13 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-78830

KIRK RANDAL J SC 13D/A 8-10-2011

Filing date
17 Aug 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .